Related Experiment Video
Updated: Mar 9, 2026
Introduction to the Ultrasound Targeted Microbubble Destruction Technique
Published on: June 12, 2011
Therapeutic Ultrasound in Cardiovascular Medicine: Applications of Low-intensity Pulsed Ultrasound and
Yucong Shi1,2, Yongqing Ye3,2, Shanshan Chang1
1Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Insights
Therapeutic ultrasound, including low-intensity pulsed ultrasound (LIPUS) and ultrasound-targeted microbubble destruction (UTMD), shows promise for treating cardiovascular disease (CVD). These advanced techniques offer non-invasive, precise, and personalized options beyond conventional therapies.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Physics
Background:
- Cardiovascular disease (CVD) poses a significant global health burden, with existing treatments having limitations.
- Conventional CVD therapies face challenges in efficacy and patient outcomes.
- Emerging medical technologies are sought to improve CVD management.
Purpose of the Study:
- To review the current landscape of cardiovascular disease (CVD).
- To discuss the potential of therapeutic ultrasound in CVD management.
- To explore the applications of low-intensity pulsed ultrasound (LIPUS) and ultrasound-targeted microbubble destruction (UTMD) for CVD.
Main Methods:
- Literature review of therapeutic ultrasound applications in cardiovascular disease.
- Analysis of low-intensity pulsed ultrasound (LIPUS) mechanisms and benefits.
- Evaluation of ultrasound-targeted microbubble destruction (UTMD) for gene delivery in CVD.
Main Results:
- Therapeutic ultrasound offers non-invasive, safe, and precise treatment options for CVD.
- Low-intensity pulsed ultrasound (LIPUS) provides biological effects with minimal thermal impact.
- Ultrasound-targeted microbubble destruction (UTMD) presents a safe and personalized gene delivery system.
Conclusions:
- LIPUS and UTMD demonstrate distinct advantages in managing cardiovascular disease.
- These ultrasound-based modalities represent promising future directions for CVD treatment.
- Further research into LIPUS and UTMD applications can enhance cardiovascular care.
Abstract:
Cardiovascular disease (CVD) represents a significant global health challenge, with its high incidence and mortality rates placing a substantial burden on both patients and society. Although conventional therapies have achieved certain results, they continue to face considerable limitations. In recent years, therapeutic ultrasound has emerged as a promising medical technology, offering notable potential in the treatment of CVD owing to its non-invasiveness, safety, and targeting precision. Low-intensity pulsed ultrasound (LIPUS), a form of therapeutic ultrasound, uses pulsed, low-intensity, moderate-frequency acoustic waves to produce biological effects. This modality minimizes thermal impact while enhancing mechanical interactions. Another well-regarded technique is ultrasound-targeted microbubble destruction (UTMD), an innovative gene delivery system characterized by safety, reliable targeting, and high personalization. In clinical practice for CVD, both LIPUS and UTMD exhibit distinct advantages. This review examines the current landscape of CVD and discusses the potential and future applications of LIPUS and UTMD in their management.
